Left atrial volume is not an index of left ventricular diastolic dysfunction in patients with sickle cell anaemia  by Hammoudi, Nadjib et al.
AC
L
v
w
L
d
d
i
v
S
c
1rchives of Cardiovascular Disease (2015) 108, 156—162
Available  online  at
ScienceDirect
www.sciencedirect.com
LINICAL RESEARCH
eft  atrial  volume  is  not  an  index  of  left
entricular  diastolic  dysfunction  in  patients
ith  sickle  cell  anaemia
e  volume  atrial  gauche  ne  constitue  pas  un  paramètre  de
ysfonction  diastolique  chez  les  patients  atteints  de
répanocytose  homozygote
Nadjib  Hammoudia,b,c,∗,  Magali  Charbonnierd,
Pierre  Levye,  Morad  Djebbara,b,
Katia  Stankovic  Stojanovic f,  Stéphane  Ederhyd,
Robert  Girotb,f, Ariel  Cohenb,d,  Richard  Isnarda,b,c,
Franc¸ois Lionnetb,f
a Department  of  Cardiology,  AP—HP,  Pitié-Salpêtrière  Hospital,  75651  Paris,  France
b University  Paris  6,  Faculté  de  Médecine  Pierre-et-Marie-Curie,  75252  Paris,  France
c UMRS  INSERM-UPMC  1166  and  Institute  of  Cardiometabolism  and  Nutrition  (ICAN),
75013 Paris,  France
d Department  of  Cardiology,  AP—HP,  Saint-Antoine  Hospital,  75571  Paris,  France
e Public  Health  Department,  Hôpital  Tenon,  AP—HP,  Institut  Pierre-Louis  de  Santé  Publique,
Inserm, UPMC-Paris  6,  UMRS  1136,  75970  Paris,  France
f Department  of  Internal  Medicine,  Reference  Centre  for  Adult  Sickle  Cell  Disease,  AP—HP,
Tenon Hospital,  75970  Paris,  France
Received  4  August  2014;  received  in  revised  form  17  September  2014;  accepted  29  September
2014
Available  online  7  February  2015
Abbreviations: A, Late peak diastolic velocity of the mitral inﬂow; DD, Diastolic dysfunction; E, Early peak diastolic velocity of the mitral
nﬂow; e′, Early diastolic tissue velocity at the septal mitral annulus level; LA, Left atrial/atrium; LAVi, Left atrial volume index; LV, Left
entricle/ventricular; LVMi, Left ventricular mass index; LVEF, Left ventricular ejection fraction; ROC, Receiver operating characteristic;
CA, Sickle cell anaemia.
∗ Corresponding author. Institut de cardiologie, groupe hospitalier Pitié-Salpêtrière, AP—HP, 47—83, boulevard de l’Hôpital, 75651 Paris
edex 13, France.
E-mail address: nadjib.hammoudi@psl.aphp.fr (N. Hammoudi).
http://dx.doi.org/10.1016/j.acvd.2014.09.010
875-2136/© 2014 Elsevier Masson SAS. All rights reserved.
Left  atrial  remodelling  in  sickle  cell  anaemia  157
KEYWORDS
Left  atrial  volume;
Sickle  cell  disease;
Diastolic  dysfunction;
LA  remodelling;
Anaemia
Summary
Background.  —  Left  ventricular  diastolic  dysfunction  (LVDD)  is  common  in  sickle  cell  anaemia
(SCA). Left  atrial  (LA)  size  is  widely  used  as  an  index  of  LVDD;  however,  LA  enlargement  in  SCA
might also  be  due  to  chronic  volume  overload.
Aim. —  To  investigate  whether  LA  size  can  be  used  to  diagnose  LVDD  in  SCA.
Methods.  —  One  hundred  and  twenty-seven  adults  with  stable  SCA  underwent  echocardiographic
assessment.  LA  volume  was  measured  by  the  area—length  method  and  indexed  to  body  surface
area (LAVi).  Left  ventricular  (LV)  ﬁlling  pressures  were  assessed  using  the  ratio  of  early  peak
diastolic velocities  of  mitral  inﬂow  and  septal  annular  mitral  plane  (E/e′).  Using  mitral  inﬂow
proﬁle and  E/e′,  LV  diastolic  function  was  classiﬁed  as  normal  or  abnormal.  LAVi  >  28  mL/m2 was
used as  the  threshold  to  deﬁne  LA  enlargement.
Results.  —  The  mean  age  was  28.6  ±  8.5  years;  there  were  83  women.  Mean  LAVi  was
48.3 ±  11.1  mL/m2 and  124  (98%)  patients  had  LA  dilatation.  In  multivariable  analysis,  age,
haemoglobin  concentration  and  LV  end-diastolic  volume  index  were  independent  determinants
of LAVi  (R2 =  0.51;  P  <  0.0001).  E/e′ was  not  linked  to  LAVi  (P  =  0.43).  Twenty  patients  had
LVDD; when  compared  with  patients  without  LVDD,  they  had  a  similar  LAVi  (52.2  ±  14.7  and
47.5 ±  10.2  mL/m2,  respectively;  P  =  0.29).  Receiver  operating  characteristics  curve  analysis
showed that  LAVi  could  not  be  used  to  diagnose  LVDD  (area  under  curve  =  0.58;  P  =  0.36).
Conclusion.  —  LA  enlargement  is  common  in  SCA  but  appears  not  to  be  linked  to  LVDD.  LAVi  in
this population  is  related  to  age,  haemoglobin  concentration  and  LV  morphology.
© 2014  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé
Contexte.  —  Chez  les  patients  drépanocytaires  homozygotes  (DH),  la  dysfonction  diastolique
(DD) ventriculaire  gauche  (VG)  est  fréquente.  La  taille  de  l’oreillette  gauche  (OG)  est  couram-
ment utilisée  pour  le  diagnostic  de  DDVG,  cependant,  chez  les  DH  la  dilatation  OG  peut
également  être  liée  à  la  surcharge  volumique  secondaire  à  l’anémie.
Objectif.  —  Évaluer  le  volume  OG  indexé  (VOGi)  comme  indice  de  DDVG  chez  les  DH.
Méthodes.  —  Cent  vingt-sept  DH  en  état  stable  (28,6  ±  8,5  années,  83  femmes)  ont  bénéﬁcié
d’une échocardiographie.  Le  VOGi  a  été  mesuré  par  la  méthode  de  surface—longueur.  Les  pres-
sions de  remplissages  VG  ont  été  évaluées  par  le  ratio  des  pics  des  vélocités  proto-diastoliques
du ﬂux  transmitral  et  de  la  portion  septale  de  l’anneau  mitral  (E/e′).  La  fonction  diastolique
VG a  été  catégorisée  comme  normale  ou  anormale  en  utilisant  le  proﬁl  transmitral  et  E/e′.  Un
VOGi >  28  mL/m2 déﬁnissait  une  OG  dilatée.
Résultats.  —  Le  VOGi  moyen  était  de  48,3  ±  11,1  mL/m2 ;  124  (98  %)  patients  avaient  une
dilatation  de  l’OG.  En  analyse  multivariée,  l’âge,  le  taux  d’hémoglobine  et  le  volume  VG  télé-
diastolique  indexé  étaient  les  déterminants  du  VOGi  (R2 =  0,51  ;  p  <  0,0001)  ;  E/e′ n’était  pas
corrélé au  VOGi  (p  =  0,43).  Le  VOGi  des  patients  avec  DDVG  (n  =  20)  était  comparable  à  celui
des patients  sans  DDVG  (respectivement,  52,2  ±  14,7  et  47,5  ±  10,2  mL/m2 ;  p  =  0,29).  Le  VOGi
n’avait pas  de  valeur  pour  le  diagnostic  de  DDVG  (aire  sous  la  courbe  =  0,58  ;  p  =  0,36).
Conclusion.  — La  dilatation  OG  observée  chez  les  DH  ne  semble  pas  être  un  indice  diagnostic  de
DDVG. Dans  cette  population,  le  VOGi  est  lié  à  l’âge,  au  taux  d’hémoglobine  et  à  la  morphologie
VG.
© 2014  Elsevier  Masson  SAS.  Tous  droits  réservés.
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Sickle  cell  disease  is  one  of  the  most  common  inherited  blood
disorders  worldwide  [1].  Besides  chronic  anaemia,  many
pathophysiological  processes  contribute  to  the  complexity
of  the  disease,  including  haemolysis  and  repeated  vaso-
occlusive  events,  with  ischaemia-reperfusion  injury  leading
to  endothelial  cell  dysfunction  [1,2].
In  patients  with  homozygous  sickle  cell  disease  —  also
called  sickle  cell  anaemia  (SCA)  —  cardiac  remodelling
(
a
tncludes  left  heart  chamber  enlargement  due  to  volume
verload  induced  by  anaemia  [3].  In  addition  to  morphologi-
al  remodelling,  left  ventricular  (LV)  functional  impairment
s  common  in  these  patients.  Two  recent  studies  in  invasive
ight  heart  catheterization  have  shown  that  post-capillary
ulmonary  hypertension  is  the  most  frequent  cause  of  pul-
onary  hypertension  in  SCA  [4,5].  LV  diastolic  dysfunctionLVDD)  diagnosed  by  echocardiography  is  common  and  is
n  independent  risk  factor  for  mortality  [6,7].  In  addi-
ion,  concomitant  to  the  improvement  in  life  expectancy
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bserved  over  recent  years,  the  prevalence  of  heart  disease
n  adult  patients  has  also  increased,  and  now  represents  up
o  one-fourth  of  all  deaths  [8].  LV  ejection  fraction  (LVEF)  is
sually  preserved  in  SCA  [9].
Left  atrial  (LA)  volume  indexed  for  body  surface  area
LAVi)  is  the  most  accurate  measure  of  LA  size  by  standard
chocardiography  [10,11].  It  has  been  widely  proved  that  LA
nlargement  is  linked  to  LV  function  [12];  thus,  the  use  of
AVi  is  currently  encouraged  for  the  diagnosis  and  evalua-
ion  of  patients  with  heart  failure,  particularly  those  with
ormal  LVEF  [13,14].  To  the  best  of  our  knowledge,  deter-
inants  of  LA  size  have  not  been  investigated  in  detail  in
CA.  In  this  population  at  high  risk  of  LVDD,  LA  size  could
e  linked  to  LV  functional  impairment  and  may  be  help-
ul  in  diagnosing  this  condition.  However,  LA  remodelling
nduced  by  haematological  disorders  may  modify  the  usual
elationship  between  LA  size  and  LV  diastolic  function  [14].
he  objectives  of  this  study  were  therefore  to  characterize
he  determinants  of  LA  morphological  remodelling  in  a  large
opulation  of  patients  with  SCA  and  to  investigate  in  partic-
lar  whether  LAVi  is  related  to  LVDD  and  if  it  could  be  used
o  diagnose  this  condition.
ethods
tudy population
rom  1  March  2007  to  31  May  2011,  all  patients  with  SCA
eferred  from  the  Reference  Centre  for  Adult  Sickle  Cell
isease  of  Tenon  Hospital  to  our  echocardiography  labora-
ory  were  eligible  for  inclusion.  Patients  who  had  developed
cute  chest  syndrome,  vaso-occlusive  crisis  or  an  acute
omplication  within  the  previous  6  weeks  (including  fever,
urgery,  blood  transfusion  or  hospital  admission,  whatever
he  reason)  were  excluded  in  order  to  focus  on  a  group  of  sta-
le  patients  free  of  confounding  factors  that  could  be  linked
o  LA  size.  Other  exclusion  criteria  were:  more  than  mild
itral  regurgitation,  more  than  mild  aortic  stenosis,  more
han  mild  aortic  insufﬁciency,  any  degree  of  mitral  stenosis,
alvular  prosthesis,  pregnancy,  arteriovenous  ﬁstula  and  his-
ory  of  atrial  arrhythmia  (including  atrial  ﬁbrillation,  atrial
utter  and  other  documented  and/or  treated  atrial  rhythm
bnormality).
A  total  of  187  patients  were  considered  for  eligibility,  of
hom  60  did  not  meet  the  inclusion  criteria.  The  remaining
27  patients  constituted  the  study  population.  All  of  these
atients  were  referred  for  routine  evaluation  of  cardiac
unction  and/or  systematic  screening  for  pulmonary  artery
ypertension.
Clinical  data  were  obtained  from  a  comprehensive  review
f  each  patient’s  medical  record.  The  diagnosis  of  SCA  was
ased  on  molecular  genetic  techniques.  All  enrolled  patients
ave  their  consent  to  participate.  The  study  was  approved
y  the  institutional  committee  on  human  research.
chocardiographyransthoracic  echocardiography  was  performed  by  two
xperienced  operators  (N.  Hammoudi,  M.  Djebbar)  using  the
ivid  7  system  (GE  Healthcare,  Horten,  Norway)  or  the  iE33
ystem  (Phillips  Medical  Systems,  Andover,  MA,  USA).  Images
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ere  transferred  to  a  workstation  equipped  with  Echopac
C  software  (GE  Vingmed  Ultrasound,  Horten,  Norway)  for
fﬂine  analysis.  All  examinations  were  analysed  ofﬂine  by
wo  senior  cardiologists  (N.  Hammoudi,  M.  Charbonnier)  who
ere  blinded  to  the  clinical  data.  All  projections  were
btained  according  to  the  recommendations  of  the  Ameri-
an  Society  of  Echocardiography  [10,15]  and  measurements
ere  averaged  over  three  cardiac  cycles.
From  the  M-mode,  the  following  measurements  were
ade  at  end-diastole:  LV  internal  diameter  and  interven-
ricular  septal  and  posterior  wall  thicknesses.  LV  mass  was
erived  and  indexed  to  body  surface  area  (LVMi);  rela-
ive  wall  thickness  was  also  calculated  and  LV  remodelling
as  categorized  as  recommended  [10]. LV  hypertrophy  was
eﬁned  as  LVMi  >  95  g/m2 in  women  and  >  115  g/m2 in  men.
urther  classiﬁcation  as  either  concentric  hypertrophy  (rela-
ive  wall  thickness  >  0.42)  or  eccentric  hypertrophy  (relative
all  thickness  ≤  0.42)  was  made  [10].
From  the  two-dimensional  mode,  LA  maximal  volume
as  measured  in  all  patients  at  the  end  of  ventricular  sys-
ole,  just  before  opening  of  the  mitral  valve,  using  the
rea—length  method  from  the  apical  four-chamber  view,  and
ndexed  to  body  surface  area  [10,16].  Since  2011,  the  LA  api-
al  two-chamber  view  has  been  acquired  systematically  and
herefore  biplane  LA  volume  measurement  was  feasible  in
4  patients.  LA  enlargement  was  deﬁned  as  LAVi  >  28  mL/m2,
nd  severe  enlargement  as  LAVi  >  40  mL/m2 [10]. LV  volumes
nd  LVEF  were  measured  using  Simpson’s  biplane  method
10].
Using  the  pulsed-wave  Doppler  mode,  LV  outﬂow  tract
ime—velocity  integral,  early  and  late  peak  diastolic  veloc-
ties  of  the  mitral  (E  and  A)  inﬂow  and  E-wave  deceleration
ime  were  measured.  LV  output  was  calculated  and  indexed
o  body  surface  area  as  recommended  [15]. The  peak
′ velocity  was  used  to  calculate  the  E/e′ ratio  using
ulsed  tissue  Doppler  imaging  of  the  septal  mitral  annulus
14].
Blinded  to  the  LA  volume  measurements,  the  LV  diastolic
unction  proﬁle  was  independently  interpreted  and  cate-
orized  as  normal  or  abnormal.  DD  was  deﬁned  as  an  E/A
atio  <  1  and/or  deceleration  time  >  240  ms;  E/A  ratio  ≥  1
nd  E/e′ ratio  >  10;  E/A  ratio  >  95th  percentile  for  age;  or
eceleration  time  <  140  ms  and  E/e′ >  10.  This  classiﬁcation
f  LV  diastolic  function  has  a  prognostic  value  for  mortality
n  SCA  [7].  From  continuous-wave  Doppler,  peak  tricuspid
egurgitation  was  recorded  in  multiple  views  and  the  highest
evel  of  velocity  was  selected.
tatistical analysis
ll  quantitative  data  are  expressed  as  means  ±  standard
eviations;  qualitative  data  are  expressed  as  counts  and
ercentages.  Comparisons  between  continuous  patient  data
ere  made  using  the  Mann—Whitney  U  test.  The  Chi-square
est  or  Fisher’s  exact  test  were  used  to  compare  categori-
al  data,  as  appropriate.  Pearson’s  correlation  test  was  used
o  analyse  the  univariate  relations  between  variables.  Step-
ise  multiple  linear  regression  analysis  was  used  to  explore
he  independent  predictors  of  LAVi;  the  variables  included
n  the  analysis  were  those  associated  with  LAVi  in  univariate
nalysis,  with  a  P  value  <  0.20.
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Figure 1. Distribution of left atrial (LA) volume index in the pop-
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Receiver  operating  characteristic  (ROC)  curves  were  plot-
ted  to  determine  the  relevance  of  LAVi  for  predicting  LVDD.
In  addition,  using  the  Bland—Altman  method,  agreement
between  single-plane  and  biplane  measurement  of  LAVi  was
assessed  in  the  subgroup  of  patients  in  whom  both  apical
four-  and  two-chamber  views  were  acquired.
MedCalc  Statistical  Software,  version  12.7.7  (MedCalc
Software,  Ostend,  Belgium)  was  used  for  calculation.  A  P
value  <  0.05  indicated  statistical  signiﬁcance.
Results
The  clinical  characteristics  of  the  population  are  sum-
marized  in  Table  1.  The  mean  age  of  the  patients  was
28.6  ±  8.5  years  and  83  of  127  (65%)  patients  were  women.
The  mean  haemoglobin  concentration  was  8.9  ±  1.3  g/dL
and  in  36  (28%)  cases,  it  was  ≤  8  g/dL.  The  echocardiographic
characteristics  of  the  patients  are  summarized  in  Table  2.
One  patient  had  an  LVEF  ≤  50%,  53  (42%)  patients  had  eccen-
tric  LV  hypertrophy  and  two  (2%)  patients  had  LV  concentric
remodelling.
The  left  atrium  (LA)  was  markedly  dilated,  with  a  mean
LAVi  of  48.3  ±  11.1  mL/m2 (Fig.  1);  124  (98%)  patients  had
LA  enlargement  and  94  (74%)  had  severe  enlargement.
Univariate  relationships  between  LAVi  and  clinical  and
echocardiographic  variables  are  shown  in  Table  3.  The
LAVi  was  not  related  to  the  E/e′ ratio  (Fig.  2).  In  multi-
variable  analysis,  age,  haemoglobin  concentration  and  LV
end-diastolic  volume  index  were  independent  determinants
of  LAVi  (R2 =  0.51;  P  <  0.0001).
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Table  1  Clinical  and  biological  characteristics  of  the  populati
Characteristic  All  patients
(n =  127)a
Pat
(n  =
Age  (years)  28.6  ±  8.5  27.
Women  83  (65)  65  
Body  mass  index  (kg/m2)  21.1  ±  3.2  21.
Hydroxyurease  therapy  43  (34)  33  
History  of  SCA  complications
Acute  chest  syndrome  53  (42)  45  
Cerebral  vasculopathy  10  (7)  7  (
Priapism  8  (18)b 7/3
Leg  ulcer  14  (11)  10  
Retinopathy  35  (28)  29  
Osteonecrosis  31  (25)  27  
Laboratory  data
Haemoglobin  (g/dL)  8.9  ±  1.3c 9.0
Lactate  dehydrogenase  (U/L)  433  ±  316c 433
Bilirubin  total  (mol/L)  50.6  ±  36.1d 50.
Ferritin  (g/L)  533  ±  899c 532
Creatinine  (mol/L)  58.0  ±  15.0  56.
Data are expressed as mean ± standard deviation or number (%); DD: d
a Diastolic function was fully characterized in 123 patients.
b n = 44 men.
c n = 126.
d n = 122.
e n = 100.
f n = 19.lation (n = 127).
Diastolic  function  was  fully  characterized  in  123  patients
the  e′ value  was  missing  in  four  patients).  Twenty  (16%)
atients  had  LVDD  and  103  (84%)  patients  had  normal
V  diastolic  function  (Tables  1  and  2).  There  was  no
ifference  in  LAVi  between  subgroups  (52.2  ±  14.7  and
7.5  ±  10.2  mL/m2, respectively;  P  =  0.29).  ROC  curve  anal-
sis  showed  that  LAVi  was  not  useful  for  prediction  of  LVDD
area  under  curve  =  0.58,  95%  conﬁdence  interval  0.48—0.66;
 =  0.36)  (Fig.  3).
on.
ients  without  DD
 103)
Patients  with  DD
(n  =  20)
P value
0  ±  7.6  36.7  ±  9.1  <  0.0001
(63)  15  (75)  0.44
0  ±  3.2  21.6  ±  3.1  0.37
(32)  7  (35)  0.91
(44)  7  (35)  0.88
7)  3  (15)  0.18
8  (18)  1/5  (20)  1
(10)  4  (20)  0.22
(28)  5  (25)  0.81
(26)  3  (15)  0.55
 ±  1.3  8.6  ±  1.4  0.28
 ±  340  434  ±  193  0.86
8  ±  36.0e 49.4  ±  38.1f 0.92
± 949  455  ±  335  0.50
3  ±  14.8  63.2  ±  15.0  0.03
iastolic dysfunction; SCA: sickle cell anaemia.
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Table  2  Echocardiographic  characteristics.
Characteristic  All  patients
(n =  127)a
Patients  without  DD
(n  =  103)
Patients  with  DD
(n  =  20)
P  value
Systolic  blood  pressure  (mmHg)  114.1  ±  14.1  113.4  ±  13.6  117.2  ±  14.8  0.28
Diastolic  blood  pressure  (mmHg)  66.5  ±  9.0  66.1  ±  9.1  68.4  ±  9.2  0.32
Heart  rate  (beats/min)  70.8  ±  12.0  71.8  ±  11.2  69.1  ±  14.6  0.16
LV  end-diastolic  volume  index  (mL/m2) 89.3  ±  18.6  88.6  ±  18.1  90.6  ±  21.4  0.90
LVEF  (%) 60.3 ±  4.5 61.0  ±  4.5 59.6  ±  3.1 0.37
Cardiac  index  (L/min/m2) 4.0  ±  0.9 4.0  ±  0.8 4.2  ±  1.2 0.66
LVMi  (g/m2)  99.9  ±  24.0  98.5  ±  22.1  104.1  ±  33.5  0.77
LV  hypertrophy  53  (42)  40  (39)  9  (45)  0.79
E  (cm/s)  93.6  ±  19.6  91.9  ±  17.5  104.1  ±  26.3  0.02
E-wave  deceleration  time  (ms)  167.6  ±  34.0  166.4  ±  30.2  175.2  ±  50.4  0.63
A  (cm/s)  51.4  ±  14.2b 49.3  ±  11.0  63.0  ±  22.4  0.01
E/A  1.9  ±  0.6b 1.9  ±  0.5  1.9  ±  1.0  0.50
e′ (cm/s) 12.1  ±  2.5c 12.4  ±  2.4  10.9  ±  2.2  0.02
E/e′ 8.0  ±  2.1c 7.7  ±  1.8  9.7  ±  2.4  0.0005
LAVi  (mL/m2) 48.3  ±  11.1 47.5  ±  10.2 52.2  ±  14.7  0.29
Tricuspid  regurgitation  maximal  velocity  (m/s) 2.5  ±  0.3d 2.4  ±  0.2e 2.6  ±  0.3f 0.004
Data are expressed as mean ± standard deviation or number (%); A: late peak diastolic velocity of the mitral inﬂow; DD: diastolic
dysfunction; E: early peak diastolic velocity of the mitral inﬂow; e′: early diastolic tissue velocity at the septal mitral annulus level;
LAVi: left atrial volume index; LV: left ventricular; LVEF: left ventricular ejection fraction; LVMi: left ventricular mass index.
a Diastolic function was fully characterized in 123 patients.
b n = 126.
c n = 123.
d n = 121.
e n = 98.
f n = 19.
Table  3  Univariate  correlations  of  left  atrial  volume  index.
Variable  n  r  P  value
Age  127  0.29  0.009
Body  mass  index  127  —0.006  0.95
Systolic  blood  pressure  127  0.07  0.44
Diastolic  blood  pressure 127  0.06  0.51
Haemoglobin  126  —0.35  0.0001
Ferritin  126  0.14  0.12
Lactate  dehydrogenase  126  0.13  0.14
Bilirubin  total  122  0.03  0.75
Creatinine  127  0.12  0.19
LV  end-diastolic  volume  index  127  0.59  <  0.0001
LVEF 127  —0.11  0.24
Cardiac  index  127  0.26  0.003
LVMi  127  0.39  <  0.0001
E  127  —0.04  0.67
E-wave  deceleration  time  127  0.16  0.10
A  126  0.10  0.25
E/A  126  —0.14  0.13
e′ 123  —0.1  0.28
E/e′ 123  0.07  0.43
DD  123  0.15  0.09
Tricuspid  regurgitation  maximal  velocity  121  0.28  0.002
A: late peak diastolic velocity of the mitral inﬂow; DD: diastolic dysfunction; E: early peak diastolic velocity of the mitral inﬂow; e′:
early diastolic tissue velocity at the septal mitral annulus level; LV: left ventricular; LVEF: left ventricular ejection fraction; LVMi: left
ventricular mass index.
Left  atrial  remodelling  in  sickle  cell  anaemia  
Figure 2. Lack of correlation between left atrial (LA) volume
index and left ventricular ﬁlling pressures assessed by E/e′ (the
ratio between early peak diastolic velocities of mitral inﬂow [E]
and septal annular mitral plane [e′]).
Figure 3. Receiver operating characteristic curve analysis, show-
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Sing that left atrial volume index is not useful for prediction of
patients with abnormal left ventricular diastolic function.
In  the  24  patients  in  whom  the  apical  two-chamber
view  was  acquired,  the  Bland—Altman  analysis  demon-
strated  good  agreement  between  the  LAVi  measurements
from  the  apical  four-chamber  view  and  by  Simpson’s
biplane  method  (mean  difference  —  0.2  mL/m2,  95%  conﬁ-
dence  interval  of  mean  difference  —  1.7  to  1.2  mL/m2).
Measurements  obtained  using  both  methods  were  strongly
correlated  (r  =  0.95;  P  <  0.0001).
Discussion
In  a  large  population  of  young  adults  with  SCA  in  a  stable
condition,  we  found  that  the  LA  was  dilated  in  almost  all  of
the  patients  and  that  three-quarters  of  patients  had  a severe
dilation.  Three  factors  were  independently  linked  with  LA
size:  age,  haemoglobin  concentration  and  LV  morphological
remodelling.  In  this  population,  LAVi  was  not  independently
O
s
c
s161
inked  to  LVDD  and  could  not  be  used  to  diagnose  this  condi-
ion.
LA  enlargement  in  patients  with  SCA  has  been  reported
reviously  [17,18]; however,  to  the  best  of  our  knowl-
dge,  this  is  the  ﬁrst  study  to  investigate  the  determinants
nd  the  potential  contribution  of  LVDD  to  LA  remodelling
n  SCA.  As  expected,  we  found  a  link  between  LA  size
nd  haemoglobin  concentration.  Indeed,  reduced  blood
xygen-carrying  capacity  induces  increased  cardiac  out-
ut  [3]. During  acute  anaemia,  the  rise  in  cardiac  output
s  due  mainly  to  tachycardia;  however,  chronic  anaemia
nduces  progressive  cardiovascular  remodelling,  leading  to
n  increase  in  stroke  volume  and  cardiac  output  with  only  a
ild  rise  in  heart  rate  [18].  Volume  overload  contributes  to
ncreased  cardiac  output  by  inducing  an  increase  in  preload
nd  a substantial  enlargement  in  the  cardiac  chambers  [19].
Conﬂicting  results  have  been  reported  for  the  relation-
hip  between  age  and  LAVi  in  normal  subjects  [20,21].
owever,  in  addition  to  the  effects  of  aging  itself,  age
eﬂects  disease  duration  in  patients  with  SCA;  therefore,
he  LA  remodelling  is,  not  surprisingly,  linked  to  the  chronic
xposure  of  these  patients  to  haematological  disorders
elated  to  SCA.  As  previously  reported  in  subjects  without
CA  [20], we  found  that  LV  end-diastolic  volume  was  an  inde-
endent  determinant  of  LA  size.  This  relationship  is  in  favour
f  a  proportional  enlargement  of  the  left  ventricle  (LV)  and
he  LA  in  patients  with  SCA.  A  similar  link  between  LV  and
A  volumes  has  been  reported  in  healthy  endurance-sport
thletes  [22]; this  fact  offers  further  support  to  the  hypoth-
sis  of  a  physiological  relationship  between  the  size  of  both
avities.
Consistent  with  previous  studies  [3,6,7],  we  found  that
V  hypertrophy  and  LVDD  are  common  in  SCA.  However,
A  enlargement  was  not  independently  linked  to  LV  mass
ndex  or  to  Doppler  characterization  of  diastolic  impair-
ent.  Recently,  in  a  smaller  population  including  38  patients
ith  sickle  cell  disease,  another  research  group  reported  a
ajor  LA  enlargement.  However,  in  patients  with  and  with-
ut  DD  there  was  no  difference  in  LAVi  [23].
In  normal  subjects,  as  well  as  in  various  pathological  con-
itions,  LV  diastolic  function  is  one  of  the  most  important
eterminants  of  LA  size  [12,20,22,24]. During  diastole,  the
A  is  directly  exposed  to  pressures  in  the  LV.  With  increased
tiffness  or  non-compliance  of  the  LV,  the  LA  pressure  rises
o  maintain  adequate  LV  ﬁlling;  hence,  the  increased  atrial
all  tension  leads  to  chamber  dilatation  and  stretch  of  the
trial  myocardium  [25]. Therefore,  dilation  of  the  LA  usu-
lly  reﬂects  elevated  LV  ﬁlling  pressures  and  constitutes  a
imple  and  reproducible  diagnostic  tool  for  LVDD  and  heart
ailure  [13,24,26].  In  patients  with  SCA,  the  magnitude  of
he  LA  enlargement,  related  to  the  severity  and  duration  of
he  haematological  condition,  overshadows  the  additional
ontribution  of  LVDD.  LA  size  should  not  therefore  be  used
s  an  index  of  LVDD  in  this  population.
tudy limitations
everal  limitations  of  our  study  need  to  be  acknowledged.
ur  single-centre  population  of  patients  with  SCA  was
ubject  to  strict  inclusion  criteria  to  reduce  bias  from
onfounding  factors  linked  to  LA  enlargement.  Our  results
hould  not  be  applied  to  patients  with  the  non-homozygous
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[62  
S  variant  of  the  disease,  who  were  not  included  in  the
tudy;  the  haemoglobin  sickle  cell  patients  (SC  variant)  have
ifferent  clinical  and  biological  characteristics  [27].  We  did
ot  use  Simpson’s  biplane  method  for  assessing  LA  volume
n  all  of  the  patients.  However,  in  the  subgroup  in  whom
he  LA  two-chamber  view  was  acquired,  we  found  good
greement  between  the  biplane  and  single-plane  methods.
olume  overload  in  patients  with  SCA  seems  to  induce  a
elatively  homogenous  LA  dilatation.
onclusion
n  adult  patients  with  SCA,  LA  enlargement  is  very  com-
on  and  pronounced.  LA  size  is  related  to  age,  haemoglobin
oncentration  and  LV  morphology.  However,  LAVi  appears  not
o  be  linked  to  LVDD  and  cannot  be  used  to  diagnose  this
ondition.
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